Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've been searching for weight loss injections in Worcester, the most important thing to know upfront is this: Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines, available through a licensed prescriber after a clinical assessment, not from a shelf or a social-media seller. Both are once-weekly injections licensed in the UK for weight management in eligible adults, with strong clinical trial evidence behind them. A legitimate prescription route exists regardless of where in Worcestershire you live, because regulated online pharmacies serve the whole of the UK. What that route looks like, and how to tell a safe one from a risky one, is exactly what this page covers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for weight loss injections in Worcester assume they need to find a nearby GP or private clinic and attend in person. That assumption is understandable, but it's out of date. GPhC-registered online pharmacies are authorised to prescribe and dispense these medicines to adults across England, subject to the same clinical standards that apply in any physical setting. A GPhC-registered Independent Prescriber reviews your consultation, checks your identity and weight, and makes the prescribing decision, the geography of your postcode is irrelevant to that process.
The NHS does provide access to these medicines in some circumstances, but the criteria are strict and phased. NICE's appraisal of tirzepatide sets eligibility at BMI 35 or above plus qualifying comorbidities, and NHS rollout is gradual. Many people in Worcester won't meet the current NHS thresholds, or will face a wait that makes private treatment worth considering. Our guide to weight loss injections across Worcestershire covers the local NHS picture in more detail.
The private route through a regulated online pharmacy removes the geography barrier entirely. Your consultation is reviewed by a real prescriber, not software. If approved, your treatment is dispatched the same day (for orders placed before 12pm, Monday to Friday) and arrives by tracked DPD the next working day, in plain unbranded packaging. Worcester or Worcestershire, it makes no difference to the timeline.
Both medicines slow gastric emptying and reduce appetite, but they get there differently. Wegovy (semaglutide) activates GLP-1 receptors, gut hormone pathways involved in insulin release and feelings of fullness. Mounjaro (tirzepatide) is the only dual-agonist currently licensed for weight management in the UK, targeting both GIP and GLP-1 receptors simultaneously. In practice, many people find that appetite suppression sets in noticeably within the first few weeks at starter doses, before any titration occurs.
The clinical evidence for weight loss injections is substantial. In the SURMOUNT-1 trial, participants using tirzepatide at the highest dose lost around 20–21% of their body weight on average over 72 weeks, according to findings published in the New England Journal of Medicine. Semaglutide at 2.4mg produced an average of around 15% loss in the STEP 1 trial. These are averages from large controlled studies, individual results vary, and no outcome is guaranteed. Both medicines carry a Black Triangle (▼) designation, meaning the MHRA continues to monitor them actively. The NHS tirzepatide page is a clear starting point for patient-level information on how tirzepatide works and what to expect.
Treatment always starts at a low dose to give your system time to adjust. The clinical logic is that the starter dose keeps side effects manageable rather than delivering full therapeutic effect immediately; your prescriber titrates upward based on how you tolerate each step. That titration schedule is set by the SmPC and your prescriber, not by you.
GI effects dominate the side-effect profile for both medicines: nausea, loose stools, constipation, indigestion and burping are the most commonly reported, especially in the first days after a dose change. For most people these settle within a week or two as the body adjusts. Headache, fatigue and injection-site reactions are also reported. Less common but requiring prompt medical attention: severe, persistent abdominal pain that spreads to the back could indicate pancreatitis, and in January 2026 the MHRA issued a Drug Safety Update specifically highlighting this risk for GLP-1 medicines, seek urgent medical help if that pattern of pain develops.
On the practical side: both Mounjaro and Wegovy pens need to be stored in the fridge between 2°C and 8°C. Keeping the pen in the fridge door alongside everyday items makes it hard to forget on injection day, but the SmPC and Patient Information Leaflet set the precise storage windows and should be your reference, not this page. Missed doses, injection technique, rotation of sites (abdomen, thigh, upper arm) and what to do if you're unwell are all questions for your prescriber or the leaflet. You can report any suspected side effects directly to the MHRA through the Yellow Card scheme.
Pregnancy, breastfeeding and trying to conceive are situations where neither medicine is recommended; the same applies to under-18s. Women using oral contraceptives starting on tirzepatide should add a barrier method for the first four weeks of treatment and after each dose increase, because tirzepatide's effect on gastric motility can reduce pill absorption. If you have a history of pancreatitis, medullary thyroid cancer or certain gastrointestinal conditions, these need to be discussed with a prescriber before treatment begins. Our FAQs page covers many of these scenarios in plain terms.
The MHRA's warnings about fake weight-loss pens are not abstract. Counterfeit pens have contained insulin rather than the labelled medicine, and in 2025 enforcement teams seized roughly 20 million doses of illegally traded weight-loss medicines worth around £45m, including the first illicit UK tirzepatide manufacturing site, found in Northampton. Anyone searching for weight loss injections in Worcester, or anywhere else, should treat the following as firm red flags: a seller offering these medicines without requiring a prescription or a clinical consultation, a price that sits dramatically below current private-market rates, and discount codes or vouchers tied to POM medicines. Legitimate pharmacies appear on the GPhC register, which anyone can search at pharmacyregulation.org/registers.
The price of weight loss injections in the UK has shifted considerably. Eli Lilly raised Mounjaro's UK list price from September 2025, with the highest dose's list price rising to around £330 per four-week pen; typical private prices across the market now range roughly £149–£375 per month depending on dose and provider. A full breakdown of what those prices do and don't include is on our weight loss injection prices page. What the headline price often hides: consultation fees, prescription charges, delivery costs and ongoing clinical review support. At nume, one price covers all of that with no subscription and no auto-renewal, but pricing is visible on the treatment page, not buried in this copy.
If you'd like to understand the full range of options before deciding anything, our weight loss treatments overview lays them out clearly. And if you're curious about how other cities are navigating the same questions, the picture in Manchester, Leicester and Colchester is broadly the same, regulated online pharmacies serve all of them equally. When you're ready to take the next step, speak to our prescribers through a free consultation; there's no obligation, and a real clinician reads every response the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.